Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>

Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>

The rise in antimicrobial resistant bacteria is limiting the number of effective treatments for bacterial infections. <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i> are two of the pathogens with the highest prevalence of resistance, and with the greatest need for n...

Full description

Bibliographic Details
Main Authors:	Kylen E. Ridyard, Mariam Elsawy, Destina Mattrasingh, Darien Klein, Janine Strehmel, Carole Beaulieu, Alex Wong, Joerg Overhage
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Antibiotics
Subjects:	LL-37 polymyxin B antimicrobial resistance synergy anti-biofilm <i>Pseudomonas aeruginosa</i>
Online Access:	https://www.mdpi.com/2079-6382/12/2/389

Similar Items

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

Insight into the Mechanism of Interactions between the LL-37 Peptide and Model Membranes of <i>Legionella gormanii</i> Bacteria
by: Katarzyna Pastuszak, et al.
Published: (2023-07-01)

Susceptibility of <i>Legionella gormanii</i> Membrane-Derived Phospholipids to the Peptide Action of Antimicrobial LL-37—Langmuir Monolayer Studies
by: Katarzyna Pastuszak, et al.
Published: (2024-03-01)

High Vitamin D Concentrations Restore the Ability to Express LL37 by <i>M. tuberculosis</i>-Infected Human Macrophages
by: María Teresa Herrera, et al.
Published: (2022-02-01)

In Vitro Antifungal Activity of LL-37 Analogue Peptides against <i>Candida</i> spp.
by: Gladys Pinilla, et al.
Published: (2022-11-01)

Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular <i>Mycobacterium tuberculosis</i> with the Antimicrobial Peptide LL-37
by: Dhruva Deshpande, et al.
Published: (2020-09-01)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
by: Juanfeng Lao, et al.
Published: (2023-03-01)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022-08-01)

Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in <i>Candida auris</i>
by: Irfan A. Rather, et al.
Published: (2022-02-01)

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

<i>Candida albicans</i> Sfp1 Is Involved in the Cell Wall and Endoplasmic Reticulum Stress Responses Induced by Human Antimicrobial Peptide LL-37
by: Chun-Min Hsu, et al.
Published: (2021-09-01)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022-07-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

LL-37 Triggers Antimicrobial Activity in Human Platelets
by: Francisco Javier Sánchez-Peña, et al.
Published: (2023-02-01)

LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages
by: Kentaro Ohuchi, et al.
Published: (2023-03-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Regulation of LL-37 in Bone and Periodontium Regeneration
by: Zahra Chinipardaz, et al.
Published: (2022-09-01)

In Vitro Evaluation of the Cytotoxic Effect of <i>Streptococcus pyogenes</i> Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line
by: Alexandr N. Chernov, et al.
Published: (2022-01-01)

Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity
by: Danuta Bryzek, et al.
Published: (2020-11-01)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
by: Liam J. O’Neil, et al.
Published: (2021-09-01)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
by: Zhifang Zhang, et al.
Published: (2020-06-01)

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures
by: Kornelius Zeth, et al.
Published: (2021-05-01)

Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania
by: Ayat H. Bakr, et al.
Published: (2019-09-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

Antimicrobial Peptide LL-37 and IDR-1 Ameliorate MRSA Pneumonia in Vivo
by: Man Hou, et al.
Published: (2013-09-01)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
by: Sotiria Davidopoulou, et al.
Published: (2014-12-01)

LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation
by: Xiao-Li Luo, et al.
Published: (2019-02-01)

Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its Antibacterial and Hemolytic Activities
by: Elżbieta Kamysz, et al.
Published: (2023-03-01)

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D
by: Iacob Simona Alexandra, et al.
Published: (2013-03-01)

Long-Term Administration of LL-37 Can Induce Irreversible Rosacea-like Lesion
by: Chuanxi Zhang, et al.
Published: (2023-03-01)

Thalidomide Attenuates Skin Lesions and Inflammation in Rosacea-Like Mice Induced by Long-Term Exposure of LL-37
by: Kang Y, et al.
Published: (2022-12-01)

Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a clinical form of Chagas Disease
by: Luiz Roberto de Oliveira Junior, et al.

The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases
by: Keqiang Chen, et al.
Published: (2021-11-01)

Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer
by: Fan R, et al.
Published: (2015-12-01)

Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to Candida albicans biofilm
by: Magdalena Juszczak, et al.
Published: (2024-02-01)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
by: Kornelius Zeth, et al.
Published: (2017-11-01)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
by: Zhuxiao Ren, et al.
Published: (2022-07-01)

A Simple Synthesis and Microstructure Analysis of Human Peptide LL-37@Gold Nanoparticles (Known as LL-37@AuNPs) Conjugates as Antimicrobials and Substances for Wound Healing
by: Subaer Subaer, et al.
Published: (2023-12-01)

Expression and significance of serum vitamin D and LL-37 levels in infants with bacterial pneumonia
by: Shaojie Zhao, et al.
Published: (2022-11-01)